20642 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells; Reproductive organs; Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
IMMUNE COMPATIBLE CELLS FOR ALLOGENEIC CELL THERAPIES TO COVER GLOBAL, ETHNIC, OR DISEASE-SPECIFIC POPULATIONS
#2TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT IN SEXUAL QUALITY OF LIFE
#3AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#4COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF
#5METHOD FOR PRODUCING CELL AGGREGATES
#6METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION
#7COMPOSITIONS, DEVICES, AND METHODS RELATING TO USE OF AN AMNIOTIC MEMBRANE FETAL TISSUE PRODUCT
#8METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#9HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME
#10SUPERNATANT OF BROWN ADIPOCYTES, METHOD FOR PREPARING SAME AND UTILIZATION THEREOF
#11METHODS OF MAKING AND USING IMMUNE-TOLERIZED FETAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR HAIR LOSS TREATMENT
#12SYSTEMS FOR STEM CELL PROGRAMMING AND METHODS THEREOF
#13Vascular associated naturally pluripotent stem cell and method of isolation
#14APOPTOSIS-INDUCED STEM CELLS, PRODUCTION METHOD THEREFOR, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY OR RENAL DISEASES
#15MICROGEL-ENCAPSULATED IPSC-DERIVED NOTOCHORDAL CELLS FOR TREATMENT OF INTERVERTEBRAL DISC DEGENERATION AND DISCOGENIC PAIN
#16GENETICALLY MODIFIED CELLS AND USES THEREOF
#17PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION
#18CARDIOPROTECTIVE HEART DISEASE THERAPIES
#19GENETICALLY MODIFIED HUMAN STEM CELL EXPRESSING A MUTANT HUMAN CYTOCHROME P450 2B6 PROTEIN AND ITS USE THEREOF IN THE TREATMENT OF CANCER
#20TREATMENT OF IMMUNE DISORDERS
#21OSTEOARTHRITIS TREATMENT COMPOSITION USING iPSC-DERIVED MITOCHONDRIA
#22TREATMENT AGENT FOR HAIR DAMAGE
#23METHODS FOR MANUFACTURING AND USING IMMUNE-TOLERIZED FETAL STEM CELL-DERIVED EXTRACELLULAR VESICLES FOR OSTEOARTHRITIS TREATMENT
#24ALLOGENEIC CAR-T PLATFORM USING HLA-MATCHED BANK OF IPSCS, AND RELATED COMPOSITIONS, SYSTEMS, AND METHODS
#25Cell Population for Transplantation and Method for Producing Same
#26IMMUNE CELL INHIBITION BY IMMUNE CHECKPOINT ENGAGERS
#27COMPOSITION FOR PROMOTING ANGIOGENESIS COMPRISING EXTRACELLULAR VESICLES DERIVED FROM THREE-DIMENSIONAL SPHEROID-TYPE CELL AGGREGATE
#28COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTICS TO THE HEART
#29Methods and Systems for Improving Photodynamic Therapy by Increasing Depth of Penetration Without Concurrently Increasing Energy Deposition
#30UNIVERSAL CELL AND METHOD FOR PREPARING SAME
#31Materials and Methods for Treatment of Hemoglobinopathies
#32COMPOSITIONS AND METHODS
#33BIOARTIFICIAL VASCULAR PANCREAS
#34PHARMACEUTICAL AND COSMETIC AND METHOD FOR PROVIDING SAME
#35PAR2 MODULATION TO ALTER MYELINATION
#36ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF
#37ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION
#38PHARMACEUTICAL PREPARATIONS OF HUMAN RPE CELLS AND USES THEREOF
#39PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION
#40ENHANCED GENE DELIVERY METHODS
#41Controllable Transcription
#42METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#43ARTIFICIAL CELL DEATH POLYPEPTIDE FOR CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
#44NEURAL CELL EXTRACELLULAR VESICLES
#45MODIFIED CELLS AND METHODS OF USE THEREOF
#46BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS
#47MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#48METHODS OF IN VITRO DIFFERENTIATION OF MIDBRAIN DOPAMINE (MDA) NEURONS
#49COMPOSITION FOR TREATMENT OF WOUNDS CONTAINING STEM CELL-DERIVED EXOSOMES AND METHOD FOR PREPARING SAME
#50GENERATING CARDIAC PROGENITOR CELLS FROM PLURIPOTENT STEM CELLS USING ISOXAZOLE OR ISOXAZOLE LIKE COMPOUNDS
#51ANTIBODY RESISTANT MODIFIED RECEPTORS TO ENHANCE CELL-BASED THERAPIES
#52MITOCHONDRIAL AUGMENTATION THERAPY FOR MYELODYSPLASTIC SYNDROME
#53COMPOSITIONS FOR INHIBITING TERATOMA FORMATION AND GROWTH COMPRISING TIMP-1 AND TIMP-2 AS EFFECTIVE COMPONENTS
#54COMPOSITIONS COMPRISING A ZIM3 EFFECTOR AND METHODS OF USE THEREOF
#55MATERIALS AND METHODS FOR THE MANUFACTURE OF PLURIPOTENT STEM CELLS
#56COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
#57Methods and Systems for Improved Therapies of Genetic Diseases Using Photo-Activated Allogenic Stem Cells
#58Accelerated Protocol for the Differentiation of Podocytes from Human Pluripotent Stem Cells
#59METHODS FOR GENERATION OF PODOCYTES FROM PLURIPOTENT STEM CELLS AND CELLS PRODUCED BY THE SAME
#60VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)-HIGHLY EXPRESSING PERICYTE-LIKE CELL
#61COMPOSITIONS AND METHODS FOR CELLULAR REPROGRAMMING USING CIRCULAR RNA
#62HUMAN IPSC-DERIVED MACROPHAGE
#63PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION
#64ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A
#65HYPOIMMUNE CELLS
#66GENE THERAPY FOR WET AGE-RELATED MACULAR DEGENERATION USING IPSC-DERIVED CELLS AS VECTORS
#67NOVEL PLURIPOTENT CELLS
#68METHODS AND COMPOSITIONS FOR POTENTIATING STEM CELL THERAPIES
#69EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION
#70MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE
#71Controllable Transcription
#72EFFICIENT AND NON-GENETICALLY MODIFIED IPSC-INDUCED, INDUSTRIALIZED SINGLE CLONE SELECTION PLATFORM, AND USE
#73COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS
#74HUMAN PLURIPOTENT STEM CELL-DERIVED SECRETOME AS A BIOLOGIC FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE AND APOPTOTIC DISEASES
#75MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#76Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion
#77GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS
#78METHODS AND COMPOSITIONS USED TO MODIFY CHROMATIN ARCHITECTURE TO REGULATE PHENOTYPE IN AGING AND CANCER
#79METHOD FOR REPROGRAMMING HUMAN CELLS
#80EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION
#81METHOD OF INHIBITING LUNG OR BREAST CANCER GROWTH WITH ENGINEERED EMBRYONIC STEM-CELL DERIVED EXOSOMES COMPOSITIONS
#82TRANSPLANTED CELL PROTECTION VIA Fc SEQUESTRATION
#83GENE CORRECTION OF POMPE DISEASE AND OTHER AUTOSOMAL RECESSIVE DISORDERS VIA RNA-GUIDED NUCLEASES
#84REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS
#85COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE
#86PREVENTION OF SPACE TRAVEL ASSOCIATED BONE DENSITY LOSS BY REGENERATIVE CELL POPULATIONS
#87IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PLURIPOTENT STEM CELLS
#88METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGINEERED STABILIZATION OF EXPRESSION OF ENDOGENOUS FOXP3 GENE
#89COMPOSITIONS AND METHODS FOR THE TARGETING OF BCL11A
#90Method to Improve Therapeutic Properties of Stem Cells
#91MODIFIED IPSCS
#92COMPOSITIONS AND METHODS TO IMPROVE IPSC-EC FUNCTION
#93NATURAL KILLER CELLS WITH ENHANCED ACTIVITY
#94Controllable Transcription
#95Allograft tolerance without the need for systemic immune suppression
#96DEVELOPMENT OF AMNION-LIKE TISSUE FROM HUMAN PLURIPOTENT STEM CELLS
#97Controllable Transcription
#98Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
#99Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells
#100COMPOSITION FOR BONE REGENERATION CONTAINING HYDROGEL AND STEM CELL SPHEROID, AND USE THEREOF
#101METHOD OF TREATING AMYLOIDOSIS
#102TREATING OF NEUROLOGICAL DISORDERS USING EXTRACELLULAR VESICLES RELEASED BY HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED NEURAL STEM CELLS
#103METHOD FOR TREATING ISCHEMIA CONDITION OF TISSUE
#104MITOCHONDRIAL AUGMENTATION THERAPY
#105ACTIVATED PLURIPOTENT STEM CELL, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#106METHODS OF TREATING SYSTEMIC GRAFT- VERSUS-HOST DISEASE WITH EXTRACELLULAR VESICLES
#107TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF
#108UNIVERSAL DONOR CELLS
#109COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#110COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEREDITARY ANGIOEDEMA
#111CELLS AND METHODS OF USES AND MAKING THE SAME
#112METHODS OF TREATING SENSITIZED PATIENTS WITH HYPOIMMUNOGENIC CELLS, AND ASSOCIATED METHODS AND COMPOSITIONS
#113Method for producing retinal pigment epithelial cells
#114A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL
#115WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
#116MODIFICATION OF BLOOD TYPE ANTIGENS
#117METHODS FOR INDUCING SELECTIVE APOPTOSIS
#118COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF
#119DELIVERY DEVICES
#120ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#121PLURIPOTENT STEM CELL AND DERIVATIVE THEREOF
#122ENGINEERED MULTICELLULAR ORGANISMS
#123METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#124METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#125Vascular associated naturally pluripotent stem cell and method of isolation
#126COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION
#127UNIVERSAL DONOR CELLS
#128UNIVERSAL DONOR CELLS
#129TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
#130IMMUNOLOGICALLY COMPATIBLE AND REVERSIBLE UNIVERSAL PLURIPOTENT STEM CELL AND APPLICATION THEREOF
#131NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
#132METHODS OF PROMOTING VASCULOGENESIS
#133GENE EDITING OF LRRK2 IN STEM CELLS AND METHOD OF USE OF CELLS DIFFERENTIATED THEREFROM
#134CRYOPRESERVED ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A
#135MECHANICAL AND BIOCHEMICAL ACTIVATION AND CONTROL OF SKELETAL STEM CELLS FOR CARTILAGE REGENERATION
#136Treatment of immune disorders
#137UNIVERSAL DONOR CELLS
#138OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS
#139MITOCHONDRIA-ENRICHED GENETICALLY ENGINEERED CELLS AND USES THEREOF
#140STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE
#141Methods of treating cancer using NK cells
#142METHODS OF THERAPEUTIC PROGNOSTICATION
#143ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF
#144EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTS
#145METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL LINE FROM MESENCHYMAL STEM CELLS, AND CELL LINE OBTAINED THEREBY
#146Use of cell wall skeleton in regenerative medicine
#147TRANSPLANTED CELL PROTECTION VIA INHIBITION OF POLYMORPHONUCLEAR CELLS
#148METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM
#149APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES
#150CD24 EXPRESSING CELLS AND USES THEREOF
#151PAR2 MODULATION TO ALTER MYELINATION
#152METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS
#153ISOLATION OF FUSION-COMPETENT MYOBLASTS AND THERAPEUTIC APPLICATIONS THEREOF RELATED TO MUSCULAR DYSTROPHY
#154COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES
#155AGENT FOR TREATING OR PREVENTING VASCULAR DEMENTIA
#156FIBROBLAST-DERIVED UNIVERSAL IMMUNOLOGICAL COMPOSITION
#157THERAPY FOR INTERSTITIAL CYSTITIS BY PLURIPOTENT STEM CELLS
#158IDENTIFICATION OF SPLICING-DERIVED ANTIGENS FOR TREATING CANCER
#159COMPOSITIONS AND METHODS OF USING MULTIPOTENT STEM CELLS TO REDUCE DISEASE AND ENHANCE WELLNESS
#160METHODS AND COMPOSITIONS FOR TREATING CANCERS
#161AMELIORATION AND TREATMENT OF BRAIN DISORDER RESULTING FROM FETAL GROWTH RETARDATION USING PLURIPOTENT STEM CELLS
#162COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE
#163Neural cell extracellular vesicles
#164Methods of generating, repairing and/or maintaining connective tissue in vivo
#165CUSTOMIZED HYBRID BONE-IMPLANT GRAFTS
#166PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS
#167BCL11B Overexpression to Enhance Human Thymopoiesis and T Cell Function
#168Method for Inducing Pluripotent Stem Cells to Differentiate into Ventricular Cardiomyocytes In Vitro
#169METHOD FOR PRODUCING INSULIN-PRODUCING CELL USING DIHYDROINDOLIZINONE DERIVATIVES
#170Composition for Preventing or Treating Salivary Gland Diseases Using Cell-Derived Vesicle
#171METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#172DEVELOPMENT OF EMBRYONIC-LIKE TISSUE FROM STEM CELLS
#173THERAPEUTIC AGENT FOR MYOCARDITIS
#174Compositions and methods for treating and preventing tissue injury and disease
#175ENGINEERED ADULT-LIKE HUMAN HEART TISSUE
#176COMPOSITIONS AND METHODS FOR EDITING A MUTATION TO PERMIT TRANSCRIPTION OR EXPRESSION
#177GENETICALLY MODIFIED CELLS AND USES THEREOF
#178LOW OXYGEN TENSION ENHANCES ENDOTHELIAL FATE OF HUMAN PLURIPOTENT STEM CELLS
#179CELL CRYOPRESERVATION MEDIUM
#180Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#181HETEROGENEOUS STEM CELL POPULATION, PREPARATION METHOD THEREFOR AND USE THEREOF
#182METHOD FOR SEPARATING PANCREATIC PROGENITOR CELLS
#183PHOTORECEPTORS AND PHOTORECEPTOR PROGENITORS PRODUCED FROM PLURIPOTENT STEM CELLS
#184SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS
#185METHODS TO REBALANCE THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS
#186AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#187DNMT3A KNOCK-OUT STAT5 ACTIVATED GENETICALLY ENGINEERED T-CELLS
#188Method of treating focal segmental glomerulosclerosis
#189Universal donor cells
#190MODIFIED PLURIPOTENT CELLS
#191METHODS OF TREATING DIABETES USING DEVICES FOR CELLULAR TRANSPLANTATION
#192PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
#193Universal donor cells
#194Agent for Eliminating Pluripotent Stem Cells
#195CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS
#196Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
#197Tagged chimeric effector molecules and receptors thereof
#198METHODS FOR MEASURING THERAPEUTIC EFFECTS OF RETINAL DISEASE THERAPIES
#199DUAL ANTIGEN-RECOGNIZING iPS CELL-DERIVED CHIMERIC ANTIGEN RECEPTOR-T-CELL THERAPY
#200BIFUNCTIONAL VECTORS ALLOWING BCL11A SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF B-HEMOGLOBINOPATHIES
#201Medical device having space for assisting in embedding of bio sample in embedding material
#202IMPROVED SURVIVAL OF HUMAN CELLS DIFFERENTIATED IN VITRO BY PRPF31 GENE EXPRESSION KNOCKDOWN
#203METHODS FOR ENHANCING LIFESPAN AND/OR TREATING CELLULAR PROLIFERATIVE DISORDERS BY TRANSPLANTATION
#204COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#205COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#206MICROFLUIDICS DEVICE FOR FABRICATION OF LARGE, UNIFORM, INJECTABLE HYDROGEL MICROPARTICLES FOR CELL ENCAPSULATION
#207CELLS EXPRESSING PARATHYROID HORMONE 1 RECEPTOR AND USES THEREOF
#208MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#209Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
#210NOVEL REPROGRAMMING METHOD
#211COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS
#212MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#213Targeted in Situ Therapeutic Delivery of Secreted Factors from Stem Cells for Treatment of Damaged Tissue
#214Pharmaceutical composition and cosmetic composition
#215COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY MACROPHAGE-MEDIATED AUTOIMMUNE DISEASE COMPRISING EXOSOMES DERIVED FROM STEM CELLS THAT ARE SURFACE-MODIFIED TO TARGET ACTIVATED MACROPHAGES
#216SYSTEMIC SCLEROSIS DISEASE MODEL AND USE THEREOF
#217MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE
#218Compositions for inhibiting teratoma formation and growth comprising TIMP-1 and TIMP-2 as effective components
#219Methods for reprograming non-pluripotent cells into pluripotent stem cells
#220IMMUNOMODULATORY CELLS AND USES THEREOF
#221Compositions and Structures for Regenerating Defective or Absent Myocardium
#222Methods for Regenerating Defective or Absent Myocardium
#223METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES
#224Reprogramming Cells With Synthetic Messenger RNA
#225THERAPEUTIC AGENT OF PERIPHERAL BLOOD FLOW DISORDER
#226Materials and methods for the manufacture of pluripotent stem cells
#227REGENERATIVE ABSCOPAL EFFECTS
#228METHODS OF CELLULAR REPROGRAMMING
#229INDUCED PLURIPOTENT CELL COMPRISING A CONTROLLABLE TRANSGENE FOR CONDITIONAL IMMORTALIZATION
#230COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
#231METHOD FOR INDUCING AND DIFFERENTIATING PLURIPOTENT STEM CELLS AND USES THEREOF
#232Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
#233Gene and cell therapy using cell fusion technology
#234MITOCHONDRIAL AUGMENTATION THERAPY WITH STEM CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
#235MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#236Anti-CD117 antibodies and conjugates
#237Compositions and methods useful in regenerative medicine
#238Method for Producing Dental Pulp-Derived Cells
#239MAPC TREATMENT OF BRAIN INJURIES AND DISEASES
#240Enhancement of production of NK cells from stem cells
#241Mitochondrial augmentation therapy of muscle diseases
#242Compositions and methods for treating type 1 and type 2 diabetes and related disorders
#243MITOCHONDRIAL AUGMENTATION THERAPY OF BRAIN DISEASES
#244COMPOSITIONS AND METHODS FOR TREATING HEART DISEASE
#245Mitochondrial augmentation therapy of ocular diseases
#246MITOCHONDRIAL AUGMENTATION THERAPY OF RENAL DISEASES
#247Method of reinforcing efficacy of stem cells using ethionamide
#248MITOCHONDRIAL AUGMENTATION THERAPY FOR PRIMARY MITOCHONDRIAL DISEASES
#249MITOCHONDRIAL AUGMENTATION THERAPY OF LIVER DISEASES
#250DENTAL PULP STEM CELLS AND USES THEREOF
#251ISOLATION OF EXTRACELLULAR VESICLES BY PRECIPITATION OR IMMOBILIZATION USING POLYETHYLENIMINE AND POLYETHYLENIMINE-COATED SOLID SUPPORTS
#252METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#253Methods and compositions for inducing hematopoietic cell differentiation
#254Stem cell filtrate preparation and method for preparing same
#255PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION
#256Compositions and methods for the depletion of CD117+ cells
#257Minimal volume reprogramming of mononuclear cells
#258Anti-Ryk antibodies and methods of using the same
#259Reprogramming Cells With Synthetic Messenger RNA
#260IPSC-DERIVED SECRETOME COMPOSITIONS, AND RELATED SYSTEMS AND METHODS
#261Transplant material for treatment of heart disease
#262HEPATO-BILIARY-PANCREATIC TISSUES AND METHODS OF MAKING SAME
#263Enhanced immune effector cells and use thereof
#264SUPERNATANT OF BROWN ADIPOCYTES, METHOD FOR PREPARING SAME AND UTILIZATION THEREOF
#265Enhanced immune effector cells and use thereof
#266Methods and compositions for treating cancers
#267ALLOGRAFT TOLERANCE WITHOUT THE NEED FOR SYSTEMIC IMMUNE SUPPRESSION
#268EXTRACELLULAR VESICLES AND USES THEREOF
#269Bioartificial vascular pancreas
#270CELL PREPARATION FOR TREATING BRAIN TUMOR
#271Induced pluripotent stem cells (IPSCS) and applications thereof
#272Methods of in vitro differentiation of midbrain dopamine (mDA) neurons
#273Production and Therapeutic Uses of Epinul Cells and Differentiated Cells Derived Therefrom
#274MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA
#275STEM CELLS FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY
#276SOMATIC STEM CELLS FOR TREATING BONE DEFECTS
#277TRANSDUCTION BUFFER
#278ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF
#279MESENCHYMAL-LIKE STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS, METHODS AND USES THEREOF
#280Methods and compositions for treatment of penile defects
#281Methods and compositions for inducing hematopoietic cell differentiation
#282Method of inhibiting lung or breast cancer growth with engineered embryonic stem-cell derived exosomes compositions
#283TROPIC CELL BASED VIROTHERAPY FOR THE TREATMENT OF CANCER
#284CPC EXOSOMES MIRNA373 COMBINATION THERAPIES
#285Protein biomaterials and biocoacervates and methods of making and using thereof
#286DIAGNOSTIC AND DRUG SCREENING FOR MOLECULAR SIGNATURES OF EARLY ONSET SPORADIC PARKINSON'S DISEASE
#287Methods and compositions for inducing hematopoietic cell differentiation
#288PKC PATHWAY IN PARKINSON'S DISEASE
#289Methods for selective inhibition of pluripotent stem cells
#290Method of Treating Parkinson's Disease
#291IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
#292Materials and methods for treatment of hemoglobinopathies
#293METHOD FOR ENHANCING MIGRATION OF STEM CELLS INTO CANCER CELLS
#294METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS
#295Light mounting systems and methods
#296PLURIPOTENT STEM CELL-DIRECTED MODEL OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE FOR DISEASE MECHANISM AND DRUG DISCOVERY
#297MODULATION OF SPLENOCYTES IN CELL THERAPY
#298Compositions for Regenerating Defective or Absent Myocardium
#299COMPOSITIONS AND METHODS FOR RESTORING OR PREVENTING LOSS OF VISION CAUSED BY DISEASE OR TRAUMATIC INJURY
#300Cell population including adhesive stem cells, production method therefor and pharmaceutical composition